120 results about "Allergic transfusion reaction" patented technology

The invention discloses a preparation method of an anti-bacteria non-woven fabric and an antibacterial agent. The anti-bacteria non-woven fabric is prepared by comprising the steps of: dissolving chitosan by using lactic acid to prepare the chitosan solution; dissolving zinc lactate in deionized water to prepare the zinc lactate solution; mixing the chitosan solution with the zinc lactate solution to prepare the antibacterial agent; and modifying a non-woven fabric in an antibacterial way: adding the antibacterial agent on the non-woven fabric, drying to prepare the anti-bacteria non-woven fabric. According to the second part of antibacterial performance of fabrics in GB / T20944.2-2007, the anti-bacteria non-woven fabric prepared by the invention has bacterial inhibiting ratio more than 99 percent through absorptive method detection, is qualified through skin irritation and vagina mucosa irritation and skin allergic reaction irritation tests, and meets sanitation requirements on sanitation standard GB15980-1995 of disposable medical supplies and sanitation standard GB15979-2002 of disposable hygienic products.

The invention relates to a medicine, in particular to broad-spectrum and high-efficiency antibacterial washing liquor and a preparation method thereof. The invention is characterized in that the antibacterial washing liquor is prepared by the following materials according to the weight ratio: 0.0001-2.0 of N-coconut-oil fatty-acid acyl L-arginine ethyl ester DL-pyrrolidone carboxylate, 0.0001-1.0 of dodecyl dimethyl benzyl ammonium chloride, 10.0-99.995 of water, and the balance of auxiliary materials. The broad-spectrum and high-efficiency antibacterial washing liquor has the following characteristics and advantages that pathogenic microorganisms are killed in a broad-spectrum and high-efficiency manner; ureaplasma urealytium, gonococcocci and trichomonas vaginalis can be killed in one minute; the killing rate for escherichia coli, staphylococcus aureus and candida albicans is respectively more than 99%; non-toxic; no stimulation is caused to the skin; no allergic reaction is caused; no stimulation is caused to the eyes; no stimulation is caused to vaginal mucosa; and the pH value of a preparation is close to that in the normal vagina.

The invention relates to a novel 5, 6, 7- tri-oxygen Dihydroflavonol, shown in formula (1), the preparation method and its application. The compound can be used to prepare drug combination that can prevent hepatitis b, protect liver, treat fungal infection, prevent diseases that generates free radical during disease change including inflammation, autoimmune diseases, radiotherapy sequela, tumor, myocardial ischemia, cardiac hypertrophy, aging, allergic reaction and atherosclerosis. There are various preparations for said drug combination.

A use of ammonia oxidizing bacteria in the manufacture of a medicament and a method for treating a subject who has developed or is at risk of developing at least one of hypertension, hypertrophic organ degeneration, Raynaud's phenomena, fibrotic organ degeneration, allergies, autoimmune sensitization, end stage renal disease, obesity, diabetes type 1, osteoporosis, impotence, hair loss, cancer, aging, autism, and an autism spectrum symptom comprising positioning ammonia oxidizing bacteria close proximity of a surface of the subject, of nitric oxide and nitric oxide precursors using ammonia oxidizing bacteria.

The invention discloses an ecological gynaecological externally-applied medicine composition and a preparation method thereof. The preparation method of the composition comprises the steps of conducting sterilization on glucose, tween 80, dipotassium phosphate, sodium acetate, seven-molecule crystal water magnesium sulfate, manganese sulfate, ammonium citrate tribasic, soluble starch and yeast cream, inoculating probiotics liquid, and conducting fermentation, so that a lactobacillus fermentation culture is obtained; adding one or more types of medicinally acceptable additives to the culture, so that the ecological gynaecological externally-applied medicine composition is obtained. The ecological gynaecological externally-applied medicine composition can be used for adjusting ecological balance of the external genital tract of a woman and preventing and treating female vaginitis. Experimental results show that the medicine composition has the inhibition and killing effects on staphylococcus aureus, colon bacillus and candida albicans, no irritation is caused to skin, and no skin allergic reaction is found.

The invention discloses a traditional Chinese herbal preparation for treating chronic nasosinusitis, which consists of gypsum, honeysuckle, chrysanthemum, ligusticum wallichii, radix angelicae, mint, dried tangerine, figwort root, spina gleditsiae, radices sileris, radix rehmanniae, angelica sinensis, pollen, magnolia flower, Siberian cocklour fruit, platycodon grandiflorum, radix bupleuri, radixscutellariae, herba pogostemonis, radix puerariae, bighead atractylodes rhizome and liquorice, the medicines are composited to generate a synergistic effect of all the medicine efficacies, and the preparation has the effects of opening the inhibited lung-energy, dispelling pathogenic wind, clearing liver fire, cooling and activating blood, eliminating stagnation and discharging pus. The traditional Chinese herbal preparation adopts the pharmacological basis on treating chronic nasosinusitis that: by aiming at the etiological pathology of the chronic nasosinusitis, the traditional Chinese herbal preparation prevents bacteria, diminish inflammation, avoid allergic reaction, improve immunity of the organism and microcirculation, and promote tissue cell repair. The preparation of the invention not only is in accordance with the principle of medicine and health syndrome differentiation and treatment in China, but also is supported by modern pharmological study, so the curative effect is obvious; and the preparation has no toxic or side effect, stable long-term effect and convenience for taking, and is worth being popularized.

The invention provides acylated glycoside compounds as well as a production method and application thereof. The acylated glycoside compounds are characterized by comprising the following structural general formula: R1 is H, OH or OAc and R2 is toluenesulfonyl group and salicyl. The acylated glycoside compounds disclosed by the invention have an immune regulation function and can be used for preparing medicaments for treating rheumatoid arthritis, medicaments for treating autoimmune diseases such as systemic lupus erythematosus, eczema and parapsoriasis guttata as well as medicaments for treating various immunological diseases such as allergic reaction.

The present invention discloses a Chinese medicine for curing allergic rhinitis. It is made up by using (by wt%) 10-50% of centipede, 10-50% of ligusticum root, 5-20% of asarum, 5-20% of magnolia flower and 5-20% of scutellaria root through a certain preparation process. Said invention also provides its preparation process and concrete steps. Said medicine can be made into nose drops and nose spray preparation.

The invention discloses an application of pyrroloquinoline quinone to medicines resistant to asthma and allergic reaction. Pyrroloquinoline quinone can relieve allergic airway inflammation through antioxidant and anti-inflammatory effects, and is a potential novel medicine for the treating asthma. Pyrroloquinoline quinone has high antioxidant and anti-inflammatory effects. The in-vivo and in-vitrostudies carried out by the invention show that pyrroloquinoline quinone can reduce allergic airway inflammation by improving the immune microenvironment and regulating a JAK-STAT signaling pathway, and research shows that pyrroloquinoline quinone is safe for oral administration, so that pyrroloquinoline quinone is a potential novel medicine for treating asthma. Pyrroloquinoline quinone exists naturally in nature and can be supplemented by diet, the safety is good, the side effects are low, and the accessibility is high. Pyrroloquinoline quinone is a non-glucocorticoid immunomodulator that targets an asthma inflammatory pathway, the mechanism of medicine action is different from that of current medicines for treating asthma, and mutual complementing can be carried out.

The invention relates to an application of sulfated chlorella and spirulina composite polysaccharides in the immunoloregulation field. The sulfated composite polysaccharides have immunoloregulation activity, can enhance the neutral red phagocytosis ability of macrophages in mice, can improve the NO production ability of the macrophages and significantly improve the proliferation of splenic lymphocytes in the mice, and can improve the DNFB induced delayed allergy of the mice to enhance the immunity of the mice.

The invention provides a disinfectant wet tissue and a preparation method thereof. The disinfectant wet tissue is formed by mixing the water extract of holly leaves and an aqueous solution of chlorine dioxide, and then impregnated with sterilized non-woven fabric; the disinfectant wet tissue of the present invention The towel has a good bactericidal effect on Escherichia coli and Staphylococcus aureus. It has high sterilization rate, stable storage performance, long shelf life, no irritation to the skin, no allergic reaction to the skin, soft and thick texture, does not contain alcohol, and is safe to use , easy to carry, suitable for many places, is a good sanitary product for people's daily life and travel.

The invention relates to the medical technique field and discloses an application for preparing IV-type allergic response resistance medicament of an extract of ramulus euonymi which is a celastraceae plant. The animal models (sheep red blood cell causing mice delayed type pedal swelling, olive oil causing mice dermatitis contacta, 5-HT causing rat mastocyte in abdominal cavity releasing histamine, 5-HT inducing guinea pig ileum shrinking) which are broadly used for screening IV-type allergic response resistance in at home and abroad at present, verifies that the extract of the ramulus euonymi can obviously inhibit the mice delayed type pedal swelling caused by sheep red blood cells, the mice dermatitis contacta caused by olive oil, the rat mastocyte in abdominal cavity releasing histamine caused by 5-HT and the guinea pig ileum shrinking caused by 5-HT, thereby proving that the ramulus euonymi has exact effect in resisting IV-type allergic response, and therefore the ramulus euonymi can be used for preparing IV-type allergic response resistance medicament.

The invention provides a composition. The composition is prepared from the following components in parts by weight of 1 to 8 parts of herba cistanche, 1 to 8 parts of radix astragali seu hedysari, 1 to 8 parts of fructus ligustri lucidi and 1 to 8 parts of fructus lycii. The medicinal materials of the composition supplement each other and can be taken as a health-care product for a long time. Pharmacodynamic experiments prove that the composition can significantly enhance the delayed allergic reaction and carbon clearance phagocytic index of mice and enhance the phagocytic function of peritoneal macrophages, and has the effect of significantly enhancing immunity.